NEW! Investment Companies Centre

AstraZeneca (AZN)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£35,798m

Change Today

Price Unchanged0.000p ()

Share Price

2,475.00p

Regulatory News

Total Voting Rights 28-Nov-2008 16:00 RNS
MOTAVIZUMAB CRL 28-Nov-2008 07:00 RNS
Pulmicort Respules US litigation settlement 26-Nov-2008 07:00 RNS
Update on Abraxis agreement 25-Nov-2008 07:00 RNS
Acquisition of AstraZeneca Tika SNC 20-Nov-2008 14:38 RNS
Pulmicort 20-Nov-2008 07:00 RNS
Pulmicort 19-Nov-2008 15:45 RNS
Pulmicort 19-Nov-2008 07:00 RNS
Zactima 19-Nov-2008 07:00 RNS
Regulatory Approval 13-Nov-2008 07:00 RNS
Crestor JUPITER study results 10-Nov-2008 07:00 RNS
Directorate Change 04-Nov-2008 07:00 RNS
Total Voting Rights 31-Oct-2008 16:00 RNS
3rd Quarter Results - Part 2 of 2 30-Oct-2008 11:00 RNS
3rd Quarter Results - Part 1 of 2 30-Oct-2008 11:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 2,475.00p  
Closing Price Change 0.000p
52 Week High 2,888.00p
52 Week Low 1,748.00p
Volume 0
Shares Issued 1,446.36m
Market Cap £35,798m
Beta 0.71
RiskGrade 303

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.05% below the market average52.05% below the market average52.05% below the market average52.05% below the market average52.05% below the market average
74.36% above the sector average74.36% above the sector average74.36% above the sector average74.36% above the sector average74.36% above the sector average
Price Trend
87.19% above the market average87.19% above the market average87.19% above the market average87.19% above the market average87.19% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Income
2.08% above the market average2.08% above the market average2.08% above the market average2.08% above the market average2.08% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Growth
43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average
60.56% below the sector average60.56% below the sector average60.56% below the sector average60.56% below the sector average60.56% below the sector average

What The Brokers Say

Strong Buy 12
Buy 5
Neutral 13
Sell 3
Strong Sell 4
Total 37
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Aug-08 06-Feb-08
Paid 15-Sep-08 17-Mar-08
Amount 55.00¢ 135.00¢

Trades for 02-Dec-2008

Time Volume / Share Price
06:51 978 @ 2,413.43p
17:42 12 @ 2,417.00p

AstraZeneca Key Personnel

CEO David R Brennan
CFO Simon Lowth

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).